Bach P. Baclofen reduziert Zahl der Trinktage. MMW Fortschr Med. 2022 164(7):30.
Bach P, Hill H, Reinhard I, Gädeke T, Kiefer F, Leménager T. Reliability of the fMRI-based assessment of self-evaluation in individuals with internet gaming disorder. Eur Arch Psychiatry Clin Neurosci. 2022 272(6):1119-1134. Epub 2021 Jul 17.
Bach P, Reinhard I, Koopmann A, Bumb JM, Sommer WH, Vollstädt-Klein S, Kiefer F. Test-retest reliability of neural alcohol cue-reactivity: Is there light at the end of the magnetic resonance imaging tube?. Addict Biol. 2022 27(1):e13069. Epub 2021 Jun 15.
Bach P, Schuster R, Koopmann A, Vollstädt-Klein S, Spanagel R, Kiefer F. Plasma calcium concentration during detoxification predicts neural cue-reactivity and craving during early abstinence in alcohol-dependent patients. Eur Arch Psychiatry Clin Neurosci. 2022 272(2):341-348. Epub 2021 Feb 25.
Berhe O, Gerhardt S, Schmahl C. Clinical Outcomes of Severe Forms of Early Social Stress. Curr Top Behav Neurosci. 2022 54:417-438. Epub 2021 Oct 10.
Bordier C, Weil G, Bach P, Scuppa G, Nicolini C, Forcellini G, Perez-Ramirez U, Moratal D, Canals S, Hoffmann S, Hermann D, Vollstädt-Klein S, Kiefer F, Kirsch P, Sommer WH, Bifone A. Increased network centrality of the anterior insula in early abstinence from alcohol. Addict Biol. 2022 27(1):e13096. Epub 2021 Aug 31.
Brynte C, Aeschlimann M, Barta C, Begeman AHA, Bäcker A, Crunelle CL, Daigre C, De Fuentes-Merillas L, Demetrovics Z, Dom G, López LG, Icick R, Johnson B, Joostens P, Kapitány-Fövény M, Karsinti E, Kiefer F, Konstenius M, Levin FR, Luderer M, Markus W, Matthys F, Moggi F, Palma-Alvarez RF, Paraskevopoulou M, Ramos-Quiroga JA, Schellekens A, Soravia LM, Therribout N, Thomas A, van de Glind G, van Kernebeek MW, Vollstädt-Klein S, Vorspan F, van den Brink W, Franck J. The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study. BMC Psychiatry. 2022 22(1):625.
Deeken F, Reichert M, Zech H, Wenzel J, Wedemeyer F, Aguilera A, Aslan A, Bach P, Bahr NS, Ebrahimi C, Fischbach PC, Ganz M, Garbusow M, Großkopf CM, Heigert M, Hentschel A, Karl D, Pelz P, Pinger M, Riemerschmid C, Rosenthal A, Steffen J, Strehle J, Weiss F, Wieder G, Wieland A, Zaiser J, Vetter S, Walter H, Lenz B, Deserno L, Smolka MN, Liu S, Ebner-Priemer U, Heinz A, Rapp MA, ReCoDe Consortium
ReCoDe Consortium. Patterns of Alcohol Consumption Among Individuals With Alcohol Use Disorder During the COVID-19 Pandemic and Lockdowns in Germany. JAMA Netw Open. 2022 5(8):e2224641.
Ekhtiari H, Zare-Bidoky M, Sangchooli A, Janes AC, Kaufman MJ, Oliver JA, Prisciandaro JJ, Wüstenberg T, Anton RF, Bach P, Baldacchino A, Beck A, Bjork JM, Brewer J, Childress AR, Claus ED, Courtney KE, Ebrahimi M, Filbey FM, Ghahremani DG, Azbari PG, Goldstein RZ, Goudriaan AE, Grodin EN, Hamilton JP, Hanlon CA, Hassani-Abharian P, Heinz A, Joseph JE, Kiefer F, Zonoozi AK, Kober H, Kuplicki R, Li Q, London ED, McClernon J, Noori HR, Owens MM, Paulus MP, Perini I, Potenza M, Potvin S, Ray L, Schacht JP, Seo D, Sinha R, Smolka MN, Spanagel R, Steele VR, Stein EA, Steins-Loeber S, Tapert SF, Verdejo-Garcia A, Vollstädt-Klein S, Wetherill RR, Wilson SJ, Witkiewitz K, Yuan K, Zhang X, Zilverstand A. A methodological checklist for fMRI drug cue reactivity studies: development and expert consensus. Nat Protoc. 2022 17(3):567-595. Epub 2022 Feb 4.
Gerhardt S, Eidenmueller K, Hoffmann S, Bekier NK, Bach P, Hermann D, Koopmann A, Sommer WH, Kiefer F, Vollstädt-Klein S. A History of Childhood Maltreatment Has Substance- and Sex-Specific Effects on Craving During Treatment for Substance Use Disorders. Front Psychiatry. 2022 13:866019.
Gerhardt S, Hoffmann S, Tan H, Gerchen M, Kirsch P, Vollstädt-Klein S, Kiefer F, Bach P, Lenz B. Neural cue reactivity is not stronger in male than in female patients with alcohol use disorder. Front Behav Neurosci. 2022 16:1039917.
Gerhardt S, Karl D, Mann KF, Kiefer F, Vollstädt-Klein S. Association Between Functional and Structural Brain Connectivity of the Default Mode Network in Non-treatment Seeking Individuals With Alcohol Use Disorder. Alcohol Alcohol. 2022 57(5):540-551. Epub 2021 Dec 21.
Gerhardt S, Lex G, Holzammer J, Karl D, Wieland A, Schmitt R, Recuero AJ, Montero JA, Weber T, Vollstädt-Klein S. Effects of chess-based cognitive remediation training as therapy add-on in alcohol and tobacco use disorders: protocol of a randomised, controlled clinical fMRI trial. BMJ Open. 2022 12(9):e057707.
Grundinger N, Gerhardt S, Karl D, Mann K, Kiefer F, Vollstädt-Klein S. The effects of nalmefene on the impulsive and reflective system in alcohol use disorder: A resting-state fMRI study. Psychopharmacology (Berl). 2022 239(8):2471-2489. Epub 2022 Apr 15.
Klausen MK, Jensen ME, Møller M, le Dous N, Jensen AØ, Zeeman VA, Johannsen CF, Lee AM, Thomsen GK, Macoveanu J, Fisher PM, Gillum MP, Jørgensen NR, Bergmann ML, Enghusen Poulsen H, Becker U, Holst JJ, Benveniste H, Volkow ND, Vollstädt-Klein S, Miskowiak KW, Ekstrøm CT, Knudsen GM, Visboll T, Fink-Jensen A. Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial. JCI Insight. 2022 7(19):e159863. Epub 2022 Sep 6.
Mühle C, Mazza M, Weinland C, von Zimmermann C, Bach P, Kiefer F, Grinevich V, Zoicas I, Kornhuber J, Lenz B. Elevated Oxytocin Receptor Blood Concentrations Predict Higher Risk for, More, and Earlier 24-Month Hospital Readmissions after In-Patient Detoxification in Males with Alcohol Use Disorder. Int J Mol Sci. 2022 23(17)
Seitz KI, Gerhardt S, von Schroeder C, Panizza A, Thekkumthala D, Bertsch K, Herpertz SC, Schmahl C, Schalinski I. Measuring types and timing of childhood maltreatment: The psychometric properties of the KERF-40. PLoS ONE. 2022 17(9):e0273931.
Soravia LM, Denier N, Moggi F, Grieder M, Federspiel A, Tschuemperlin RM, Batschelet HM, Vollstädt-Klein S, Wiest R, Stein M, Bracht T. Reduced structural connectivity of the amygdala is associated with childhood trauma in adult patients with alcohol use disorder. Addict Biol. 2022 27(3):e13164.
Tan H, Nakovics H, Zeng H, Copello A, Akhtar S, Lee AM, Kiefer F, Vollstädt-Klein S. Assessment of automated craving across substances and across cultures: stability-analysis of the Craving Automated Scale (CAS). J Addict Dis. 2022 40(3):405-414. Epub 2021 Dec 30.
Türkmen C, Machunze N, Tan H, Gerhardt S, Kiefer F, Vollstädt-Klein S. Vulnerability for alcohol use disorder after adverse childhood experiences (AUDACE): protocol for a longitudinal fMRI study assessing neuropsychobiological risk factors for relapse. BMJ Open. 2022 12(6):e058645.
Vetter S, Thomas BC, Krisam J, Limprecht R, Klose C, Stenger M, Pourbaix M, Ries M, Vollstädt-Klein S, Koopmann A, Lenz B, Kiefer F, Bach P. ON-ICE trial: Investigation of the combined effects of oxytocin and naltrexone on stress-induced and alcohol cue-induced craving in alcohol use disorder-Study protocol of a phase II randomised double-blind placebo-controlled parallel-group trial. BMJ Open. 2022 12(4):e059672.
Wasmuth J, Reinhard I, Hill H, Alpers GW, Shevchenko Y, Kiefer F, Leménager T. A Smarter Way to Use Your Smartphone: An Intervention to Limit Smartphone-Related Distractions Reduces Hyperactivity but Not Inattention Symptoms. Eur Addict Res. 2022 28(4):255-266. Epub 2022 Feb 4.
Wetzel L, Pourbaix M, Riegler A, Pfeifer AM, Reinhard I, Hoffmann S, Vollstädt-Klein S, Kiefer F, Sommer WH, Bumb JM, Back P, Koopmann A. G-CuP: the effect of a forced oral glucose intake on alcohol craving and mesolimbic cue reactivity in alcohol dependence-study protocol of a randomized, double-blind, placebo-controlled crossover study. Trials. 2022 23(1):693.
Zhang J, Chen T, Tan H, Wu Q, Chen L, Yuan C, Ding J, Zhang L, Du C, Li J, Lu E, Wu Y, Zhao M, Du J. Mindfulness-based intervention on Chinese patients with Amphetamine-type stimulant use disorders: an EEG functional connectivity study. Mindfulness. 2022 13:1320-1322. Epub 2022 Apr 14.